Objective: To measure validity of C-reactive protein (CRP) as screening test for neonatal sepsis (NS) and compare its screening validity between early onset neonatal sepsis (EONS) and late onset neonatal sepsis (LONS). Study Design: Cross-sectional study Place and Duration of Study: Neonatal Unit, Town Children Hospital, Peshawar, Khyber Pukhtunkhawa, from August 2016 to February 2017. Methodology: A total of 385 neonates from age 0 to 28 days with clinical features of neonatal sepsis were sampled using consecutive sampling technique. Two groups were identified, i.e. early onset neonatal sepsis (age <72 hours) and late onset neonatal sepsis (age >72 hours). Each neonate was sampled for blood culture and C-reactive protein (CRP). Diagnosis of neonatal sepsis was established through a positive blood culture. Data was analysed using SPSS V 25.0. Sensitivity, specificity, negative predictive value (NPV) and positive predictive value (PPV) of CRP was measured and compared in each group. Results: Analysis showed a low validity of CRP as screening test in neonatal sepsis (Sensitivity=35.525%, specificity=58.0%, PPV=85% and NPV=11.83%). Initial screening test validity of CRP was low in EONS (sensitivity=17.16%, specificity=58.33%, PPV=72.72% and NPV=9.81%) compared to LONS (sensitivity=77.45%, specificity=57.14%, PPV=92.94% and NPV=25.80) Conclusion: CRP as a screening test has low screening validity in early onset neonatal sepsis compared to late onset sepsis.
INTRODUCTION
Neonatal sepsis (NS) is the 2 nd most common cause of neonatal deaths after prematurity in developing countries. 1, 2 Current neonatal mortality rate in Pakistan is 44 per 1000 live births. 3 In developing countries like Pakistan, mortality related to neonatal sepsis is three times higher than developed world. 4 NS is a systemic infection of new-borns <28 days of life, with a positive blood culture showing growth of bacteria. NS is classified in to early onset (age of presentation <72 hours) and late onset sepsis (age >72 hours). 5 Hematologic markers used to screen neonatal sepsis, include C-reactive protein, absolute neutrophil count, immature/total leukocytes ratio (I:T), and platelets count. Blood culture is the only gold standard test to confirm diagnosis of NS. 6, 7 C-reactive protein (CRP) is an acute phase protein normally produced by liver within 6 to 8 hours of acute inflammation. Its normal value ranges from 0 to 5 mg/L, (reference range varies in laboratory settings). Among inflammatory markers, CRP is a preferable screening tool in initial assessment of NS. 8 Moreover, CRP has better screening validity in NS and considered as preferable method to screen a new-born for possible NS. 9, 10 The objective of this study was to measure validity of CRP as screening test for possible NS and compare its validity between early and late onset NS rationalising that CRP being non-specific acute phase protein with misleading results before 72 hours of acute neonatal infection due to liver immaturity.
METHODOLOGY
A cross-sectional study was conducted at Neonatal Unit, Town Children Hospital (TCH), Peshawar, Khyber Pukhtunkhawa from August 2016 to February 2017.
Using WHO software for sample size calculation, anticipated proportion of neonatal sepsis (P) = (50%, Pakistan Demographic Health Survey 2006-07), confidence level (%) = 95, margin of error (d) = 0.05, standard deviation (Z) = 1.96 corresponding to 95% confidence limits, and n = Z2P (100-P)/E2 (adding 10% non-response), sample size was determined as 385 (p = 50%). Consecutive sampling technique was used to select sample till completion of sample size. Inclusion criteria were neonates from 0 to 28 days of life having clinical features suggestive of NS and willingness of parents to participate in study. Excluded patients were those who were advised antibiotics (for any reason) 24 hours before admission to neonatal unit, those positive blood cultures which showed contamination and unwillingness of parents to participate in study. Each neonate was sampled for blood culture and C-reactive protein aseptically. Diagnosis was established through a positive blood culture. CRP value of >5 mg/dl was considered positive (as per laboratory indices).
From selected sample (n=385) two groups were identified, i.e. early onset NS (age <72 hours) and late onset NS (age >72 hours). Data was analysed using SPSS v 25.0. In both groups, the validity of C-reactive protein (sensitivity, specificity, negative and positive predictive value) was calculated using 2x2 table and the results were compared.
RESULTS
Among 385 neonates, 269 (69.9%) were grouped in early onset neonatal sepsis and 116 (30.1%) as late onset neonatal sepsis. Overall positive blood cultures were found in 335 (87.0%) and negative in 50 (13.0%) cases. In early onset group, blood culture was positive in 233 (86.8%) and negative in 36 (13.4%) cases, while in late onset group, blood culture was positive in 102 (87.9%) and negative in 14 (12.1%).
Results for C-reactive protein (CRP) were positive in 140 (36.4%) and negative in 245 (63.6%) neonates. As evident from Table I in 
DISCUSSION
Current study was conducted to measure screening validity of CRP as an initial tool for screening NS. In current research, NS was investigated in 385 neonates. Three hundred and thirty-five neonates (87.0%) had culture proven NS, while 50 neonates (13.0%) had only clinical sepsis. This study concluded a higher percentage of NS compared to other studies concluded by Karamat et al. 11 , Goheer et al. 4 , Mane et al., 9 and Ansari et al. 12 This higher rate was reported due to selection of cases having clinical features of NS. Similar prevalence was also reported by Butt et al. 13 Current research showed EONS in 269 neonates (69.9%) and LONS in 116 neonates (30.1%). Similar results were reported by others. 4, 9, 12 A higher rate of EONS compared to LONS was reported due to poor antenatal coverage of high risk deliveries and delayed maternal sepsis screen. 14 CRP was positive in 140 (36.4%) cases. In EONS group, 55 (20.4%) neonates had positive CRP; whereas in LONS it remained positive in 85 (73.3%) neonates. Validity of CRP (sensitivity, specificity, positive predictive value, and negative predictive value) in NS (EONS & LONS) remained 35.52%, 58.0%, 85.0%, and 11.83%, respectively. In early onset, NS validity of CRP (sensitivity, specificity, positive predictive value, and negative predictive value) as initial screening test remained 17.16%, 58.33%, 72.72%, and 9.8%, respectively; while in late onset, sepsis validity (sensitivity, specificity, positive predictive value, and negative predictive value) of CRP was 77.45%, 57.14%, 92.94%, and 25.80%, respectively. This difference in study results were reported by Anwer et al. 5 , Butt et al. 13 , Shirazi et al. 6 , Vergnano et al. 10 , Naher et al. 15 , Cetin et al. 16 , Lee et al. 17 , Kordek et al. 18 and Hisamuddin et al. 19 Study results indicate that in comparison to late onset NS, CRP has a low validity as screening biomarker in early onset NS.
The study has certain limitations. Results might be more indicative, if other screening tests like total leukocytes/ Absolute neutrophil count (ANC) also considered as one of the screening biomarkers for NS and results compared accordingly with blood culture. Study would have been improved, if determinants of NS included with comparison drawn between early and late onset sepsis. test to screen NS before 72 hours of birth; however, it has better screening accuracy in late onset sepsis. In early onset NS CRP should not be used as initial screening test instead of other tests should be relied upon until confirmation of blood culture.
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